DUBLIN--(BUSINESS WIRE)--The "Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User, and Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global neurodiagnostics market is projected to grow at a CAGR of 7.3% during the forecast period.
The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. The demand for neurodiagnostic products is expected to grow due to the increasing prevalence of neurological disorders & diseases. The neurodiagnostics market is segmented on product, condition, end-user, and region.
The hospitals & surgical centers segment accounted for the largest share of the neurodiagnostics market by end-user in 2018.
Based on end-user, the neurodiagnostics market is segmented into hospitals & surgical centers, diagnostic laboratories & imaging centers, neurology centers, ambulatory care centers (ACCs), and research laboratories & academic institutes. In 2018, hospitals & surgical centers accounted for the largest share of the neurodiagnostics market due to the financial capabilities of hospitals to purchase expensive equipment, such as neurodiagnostic devices.
The neurodegenerative diseases segment accounted for the largest share of the neurodiagnostics market by condition in 2018.
The neurodiagnostics market, by condition, is segmented into neurodegenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and other conditions. In 2019, the neurodegenerative diseases segment is expected to account for the largest share of the neurodiagnostics market due to the increasing incidence of traumatic brain injuries, dementia, Parkinson's disease, and Huntington's disease, and the growing number of neurological examinations for the diagnosis of these conditions.
North America accounted for the largest share of the neurodiagnostics market in 2018.
North America accounted for the largest share of the neurodiagnostics market in 2018, followed by Europe. This can primarily be attributed to the presence of a highly developed healthcare system, high adoption of innovative neurodiagnostic devices among medical professionals, full availability of advanced neurodiagnostic tools, and the large number of neurodiagnostic devices manufacturing companies that have an established base or are headquartered in the US.
This report studies the neurodiagnostics market based on product, condition, end-user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the neurodiagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Key Topics Covered:
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency Used for the Study
1.5 Major Market Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Market Estimation Methodology
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 Neurodiagnostics Market, By Product, 2019 Vs. 2024
4.3 Market Share, By End User and Region (2019)
4.4 Market, By Condition, 2019 Vs. 2024 (USD Million)
4.5 Market, By Country
5 Market Overview
5.2 Market Dynamics
6 Neurodiagnostics Market, By Product
6.2 Diagnostic Imaging Systems
6.3 Clinical Diagnostic Instruments
6.4 Reagents & Consumables
7 Neurodiagnostics Market, By Condition
7.2 Neurodegenerative Diseases
7.5 Headache Disorders
7.6 Sleep Disorders
8 Neurodiagnostics Market, By End User
8.2 Hospitals & Surgical Centers
8.3 Diagnostic Laboratories & Imaging Centers
8.4 Neurology Centers
8.5 Ambulatory Care Centers
8.6 Research Laboratories & Academic Institutes
9 Neurodiagnostics Market, By Region
9.2 North America
9.4 Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape
10.2 Market Share Analysis
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping
11 Company Profiles
11.1 GE Healthcare
11.2 Philips Healthcare
11.3 Siemens Healthineers
11.4 Hitachi, Ltd.
11.5 Canon, Inc.
11.6 Lifelines Neuro Company, LLC
11.7 Natus Medical Incorporated
11.8 F. Hoffmann-La Roche AG
11.9 FUJIFILM Holdings Corporation
11.10 Mitsar Co., Ltd.
11.11 Advanced Brain Monitoring, Inc.
11.12 Thermo Fisher Scientific, Inc.
11.13 Bio-Rad Laboratories
11.14 QIAGEN N.V.
11.15 Nihon Kohden Corporation
11.16 Other Companies
11.16.1 ANT Neuro
11.16.2 Fonar Corporation
11.16.3 Fujirebio (A Part of Miraca Group)
11.16.4 DRG Instruments GmbH
11.16.5 Tecan Trading AG
For more information about this report visit https://www.researchandmarkets.com/r/hvqhqe